Clinical Trial: Dosimetry Guided PRRT With 177Lu-DOTATATE in Children

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT03923257) titled 'Dosimetry Guided PRRT With 177Lu-DOTATATE in Children' on March 29.

Brief Summary: This is a Phase I/II peptide receptor radiotherapy (PRRT) trial of 177Lu-DOTA-OCTREOTATE in children with relapsed or refractory neuroblastoma, neuroendocrine tumors, and pheochromocytoma or paraganglioma.

Study Type: Interventional

Condition: * Neuroendocrine Tumors

* Neuroblastoma

* Pheochromocytoma

* Paraganglioma

Intervention: * Drug: 177Lu-DOTA-tyr3-OCTREOTATE

This is a peptide receptor radiotherapy that targets somatostatin receptors on tumor cells.

Other Name: Lutathera

* Procedure: Peptide Receptor Radiotherapy (PRRT)

PRRT is intern...